Use of Phosphorothioate-Modified Oligodeoxynucleotides to Inhibit NF-κB Expression and Lymphocyte Function
- 1 February 1998
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 86 (2), 170-179
- https://doi.org/10.1006/clin.1997.4486
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.Journal of Clinical Investigation, 1994
- Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.Molecular and Cellular Biology, 1992
- Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli.Molecular and Cellular Biology, 1991
- Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.Molecular and Cellular Biology, 1990
- Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B.Molecular and Cellular Biology, 1990
- Kappa B-Specific DNA Binding Proteins: Role in the Regulation of Human Interleukin-2 Gene ExpressionScience, 1989
- Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factorCell, 1988
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCell, 1986
- Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.The Journal of Experimental Medicine, 1981